Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | < 0.001 | 1 | 2016 | 2016 | ||||||
|
0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | < 0.001 | 1 | 2016 | 2016 | ||||||
|
0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | < 0.001 | 1 | 2016 | 2016 | ||||||
|
0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 |
|
Neoplasms | 0.020 | 0.500 | 2 | 2015 | 2018 | ||||||
|
0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 |
|
Neoplasms | 0.030 | 0.667 | 3 | 2015 | 2018 | ||||||
|
0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 |
|
Neoplasms | 0.050 | 0.800 | 5 | 2013 | 2017 | ||||||
|
0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 |
|
Neoplasms | 0.050 | 0.800 | 5 | 2013 | 2017 | ||||||
|
0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 |
|
Neoplasms | 0.080 | 0.875 | 8 | 2013 | 2020 | ||||||
|
0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 |
|
Neoplasms | 0.100 | 0.909 | 11 | 2011 | 2020 | ||||||
|
0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 |
|
Neoplasms | 0.100 | 1.000 | 17 | 2011 | 2019 | ||||||
|
0.708 | 0.320 | 15 | 90088702 | missense variant | C/A;T | snv | 3.2E-05 |
|
Neoplasms | 0.780 | 1.000 | 16 | 2010 | 2019 | |||||||
|
0.689 | 0.200 | 15 | 90088606 | missense variant | C/A;T | snv |
|
Neoplasms | 0.720 | 1.000 | 12 | 2010 | 2016 | ||||||||
|
0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 |
|
Neoplasms | 0.060 | 1.000 | 6 | 2013 | 2017 | ||||||
|
0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 |
|
Neoplasms | 0.060 | 1.000 | 6 | 2013 | 2017 | ||||||
|
0.851 | 0.120 | 15 | 90088681 | missense variant | A/C | snv | 8.0E-06 |
|
Immune System Diseases; Hemic and Lymphatic Diseases | 0.060 | 1.000 | 6 | 2014 | 2019 | |||||||
|
0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 |
|
Neoplasms | 0.050 | 1.000 | 5 | 2014 | 2019 | ||||||
|
0.763 | 0.280 | 15 | 90088703 | missense variant | G/A;C | snv |
|
Neoplasms | 0.710 | 1.000 | 5 | 2010 | 2016 | ||||||||
|
0.752 | 0.160 | 15 | 90088605 | missense variant | C/G | snv |
|
Neoplasms | 0.700 | 1.000 | 4 | 2011 | 2014 | ||||||||
|
0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 |
|
Neoplasms | 0.040 | 1.000 | 4 | 2015 | 2020 | ||||||
|
0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 |
|
Neoplasms | 0.030 | 1.000 | 3 | 2013 | 2016 | ||||||
|
0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 |
|
Neoplasms | 0.030 | 1.000 | 3 | 2013 | 2016 | ||||||
|
0.708 | 0.320 | 15 | 90088702 | missense variant | C/A;T | snv | 3.2E-05 |
|
Neoplasms | 0.030 | 1.000 | 3 | 2013 | 2015 | |||||||
|
0.708 | 0.320 | 15 | 90088702 | missense variant | C/A;T | snv | 3.2E-05 |
|
Hemic and Lymphatic Diseases | 0.720 | 1.000 | 3 | 2010 | 2016 | |||||||
|
0.708 | 0.320 | 15 | 90088702 | missense variant | C/A;T | snv | 3.2E-05 |
|
Neoplasms | 0.030 | 1.000 | 3 | 2013 | 2015 | |||||||
|
0.752 | 0.160 | 15 | 90088605 | missense variant | C/G | snv |
|
Neoplasms | 0.020 | 1.000 | 2 | 2017 | 2019 |